Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Sundvall

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|December 23, 2008
Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancerDenis Tvorogov, Maria Sundvall, Kari Kurppa, et al.
Scientific Reports|November 10, 2018
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatinElli Narvi, Katri Vaparanta, Anna Karrila, et al.
Plos One|July 19, 2014
ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancerKari J Kurppa, Matjaz Rokavec, Maria Sundvall, et al.
Molecular Biology of the Cell|October 15, 2010
Cell death or survival promoted by alternative isoforms of ErbB4Maria Sundvall, Ville Veikkolainen, Kari Kurppa, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2008
Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoformsMaria Sundvall, Anna Korhonen, Ilkka Paatero, et al.
The Journal of Pathology|October 6, 2025
Androgen receptor-mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancerSaiganesh Sriraman, Verneri Virtanen, Antti Kukkula, et al.
Cancer Research|March 1, 2005
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cellsTeemu T Junttila, Maria Sundvall, Mikael Lundin, et al.
Molecular Biology of the Cell|October 28, 2005
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growthJorma A Määttä, Maria Sundvall, Teemu T Junttila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cellsKaisa Erjala, Maria Sundvall, Teemu T Junttila, et al.
The Journal of Biological Chemistry|May 16, 2012
Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 proteinMaria Sundvall, Anna Korhonen, Katri Vaparanta, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|December 23, 2008
Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancerDenis Tvorogov, Maria Sundvall, Kari Kurppa, et al.
Scientific Reports|November 10, 2018
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatinElli Narvi, Katri Vaparanta, Anna Karrila, et al.
Plos One|July 19, 2014
ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancerKari J Kurppa, Matjaz Rokavec, Maria Sundvall, et al.
Molecular Biology of the Cell|October 15, 2010
Cell death or survival promoted by alternative isoforms of ErbB4Maria Sundvall, Ville Veikkolainen, Kari Kurppa, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2008
Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoformsMaria Sundvall, Anna Korhonen, Ilkka Paatero, et al.
The Journal of Pathology|October 6, 2025
Androgen receptor-mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancerSaiganesh Sriraman, Verneri Virtanen, Antti Kukkula, et al.
Cancer Research|March 1, 2005
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cellsTeemu T Junttila, Maria Sundvall, Mikael Lundin, et al.
Molecular Biology of the Cell|October 28, 2005
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growthJorma A Määttä, Maria Sundvall, Teemu T Junttila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cellsKaisa Erjala, Maria Sundvall, Teemu T Junttila, et al.
The Journal of Biological Chemistry|May 16, 2012
Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 proteinMaria Sundvall, Anna Korhonen, Katri Vaparanta, et al.
Pageof 4